Army Medical Operational Capabilities for 2040 BAA
Executive Summary:
The MED CDID Broad Agency Announcement (BAA) invites industry and other performers to propose innovative medical concepts and technologies that support tactical Army medical units in the 2040 Future Operational Environment. The program is open through December 31, 2030, using a multi-step process: submission of a Vulcan Scout Card, followed—if selected for further interest—by a white paper and then a full technical and cost proposal. Companies should plan their internal timelines to first shape a high-impact Scout Card aligned to MED CDID’s three imperatives: clearing the battlefield, maximizing return to duty, and overcoming contested logistics.
How much funding would I receive?
The MED CDID BAA does not specify individual award ceilings or a total program funding limit. Instead, offerors must propose a Rough Order of Magnitude (ROM) total cost (including any fee) that is consistent with the scope of work, period of performance, and any dollar ranges specified in the announcement or follow-on calls. Common costs range from $500K to $5M.
What could I use the funding for?
Proposals should address at least one problem associated with the following aspects of the future operational environment (FOE):
a. Enemy action (through fires, maneuver, electronic warfare, etc.) will inhibit evacuation and medical resupply operations. Slow, reduced, or ineffective evacuation or medical resupply delays the Soldier’s treatment at the proper medical treatment facility. When evacuation slows, the consumption of medical treatment items increases, thus compounding the resupply problem. The cumulative effects of inadequate evacuation and medical resupply will reduce the return to duty rate and increase the number of preventable deaths.
b. The proliferation of drones, sensors, and other advanced technologies has made the modern battlefield more transparent than ever before. This transparency, coupled with long range precision and massed fires, requires Army forces to be distributed across a wider area and to displace frequently. Enemy precision and massed fires will result in more frequent mass casualty incidents, which will likely occur in support areas rather than near the front lines. Future medical forces must therefore be highly mobile to conduct survivability moves, to support widely distributed units, and to respond quickly to the point of need with both medical personnel and supplies (Class VIII).
c. The future battlefield will likely have a broad range of man-made and naturally occurring chemical and biological threats. These threats may be varied and difficult to detect and prevent, making early warning systems crucial. Toxic industrial chemicals and toxic industrial materials in urban areas pose additional threats. Directed energy and other new weapons may cause novel wound patterns that require new training and treatments.
d. When operating in urban areas, challenges include moving through routes blocked by rubble, craters, and other obstacles. Medical units must plan to extract patients from collapsed buildings, interaction with civil medical infrastructure, and potentially large numbers of injured civilians and enemy prisoners.
e. An increasingly transparent and lethal battlefield with chem-bio threats and new weapons systems will create continuous physiological and psychological stressors. These stressors will lead to a decline in the cognitive, physical, and emotional aspects of Soldier performance, and thus a decline in unit combat effectiveness. Army medical units must expand capacity to build and restore individual resiliency, to reduce disease non-battle injury (DNBI) losses, and increase return to duty (RTD).
AREAS OF INTEREST
The Army is looking for solutions in the following categories. Please note that these categories are not comprehensive, but rather to provide context. Categories may be created or removed as time progresses:
-
Future wars will produce dramatically higher casualty numbers that will stress patient evacuation systems and restrict freedom of maneuver. Minimizing preventable death requires a multi-modal medical evacuation (MEDEVAC) system with advanced enroute care from the point of injury (POI) to the appropriate medical treatment facility at echelon. This MEDEVAC system must be mobile, survivable, and sustainable. It will leverage manned as well as autonomous and semi-autonomous platforms, integrate with casualty evacuation (CASEVAC) capabilities, and be synchronized to maximize efficiency.
a. Autonomous / semi-autonomous platforms. Manned evacuation platforms areexpected to be insufficient for future combat operations with peer adversaries or in non-permissive environments. The Army's Robotics and Autonomous System (RAS) Strategy leverages systems to increase reach, capacity, and protection in high-risk areas. Unmanned aerial systems (UAS) and unmanned ground vehicles (UGVs) can be staged with support units to provide delivery of critical medical supplies when evacuation is not possible (i.e., prolonged care). A versatile unmanned system (UMS) with casualty evacuation capability would serve as a valuable tool for medical missions.
b. CASEVAC. CASEVAC complements MEDEVAC by providing additional evacuation capacity when the number of casualties (workload) or mandated reaction time exceeds the capabilities or capacity of MEDEVAC assets. Casualty evacuation is often the first step in moving patients from the point of injury to the appropriate medical facility. Self-aid and buddy-aid are critical. Effective operational planning and a C2 system that integrates non-standard platforms maximizes the commander’s freedom of action and ensures efficient use of evacuation assets. Augmentation of medical personnel and equipment onboard dedicated CASEVAC platforms will increase survivability.
c. Multimodal evacuation. Multimodal evacuation capabilities meet FOE challenges by using multiple modes of transportation (e.g. boats, buses, trains, etc.) to fulfill evacuation capability and capacity shortfalls. Future evacuation capabilities involve the seamless integration of land, air, and maritime (sea and river) transportation to ensure an efficient and effective evacuation system. Leveraging different modes of transportation optimizes mobility and flexibility, enhances response capabilities, and enables swift evacuation in a variety of operational environments.
d. Prolonged Care. The FOE may not allow evacuation of patients at a time and place of our choosing, due to unavailability of assets or enemy action. Prolonged care is necessary to provide patient care for extended periods when evacuation is not available. Currently, the Prolonged Care Augmentation Detachment (PCAD) is designed to operate forward of definitive care capabilities in support of medical units, such as Battalion Aid Stations (BAS), medical companies, and Forward Resuscitation and Surgical Detachments (FRSD) to manage patients in a prolonged care setting. Further study is needed to determine if this capability can be significantly improved.e. Integrated and synchronized C2 of patient movement capabilities. C2 systems facilitate seamless communication and information sharing among healthcare providers, commanders, evacuation elements, and other stakeholders involved in patient movement. These systems enable real-time coordination, synchronization, and decision-making, ensuring efficient and effective allocation of resources for patient movement. An integrated C2 system incorporates AI-enabled real-time data analysis, predictive modeling, and adaptive learning to enable the following: mission requests management, treatment and evacuation capability tracking and two-way communication, intelligent tasking (dispatching), data management, and telemedicine and telehealth technologies to facilitate remote consultations, triage, and medical guidance during patient movement. These solutions enable evacuation mission and system management and enable healthcare providers to remotely assess and manage patients. They also allow optimization of medical personnel, equipment, supplies, and evacuation resources based on patient needs, urgency, and available capacity.
-
Maximizing RTD allows for experienced Soldiers to return to the fight as quickly as possible after becoming wounded, injured, or ill. It includes prevention—minimizing disease and nonbattle injury (DNBI).
a. Holistic resiliency. Commanders in conjunction with their medical staff will maximize preparedness through a holistic approach prior to and during deployment. This will serve to help minimize DNBI and battle injuries (BI). A holistic approach includes cognitive, physical, and emotional well-being, emphasizing proper nutrition, sleep, and social and environmental factors to navigate the rigors of combat operations. Advances in areas such as body-worn sensors, stress inoculation, and medical cognitive enhancements will further increase Soldiers’ capabilities in austere environments while decreasing the likelihood of becoming a casualty. Advanced biomedical engineering can create vaccines and individualized treatments to address emerging health threats before deployment to preserve the force.
b. Theater Convalescence. In the theater of operations, convalescence capability is essential to maximizing RTD rates. Soldiers who are unlikely to RTD within the prescribed period (theater evacuation policy) will be evacuated out of theater with the first suitable transportation asset. Establishing in-theater convalescence serves to simultaneously decrease the logistical burden on theater transportation assets while decreasing the burden on replacement operations. Rehabilitation support encompasses cognitive and emotional healing as well as physical recovery (e.g., physical therapy with combat and operational stress control). Advanced prosthetics, exoskeletons, and robotic rehabilitation systems can assist Soldiers in regaining mobility and functionality after injury.
c. Operational Public Health (OPH). OPH is a critical enabler for commanders to maintain maximum strength on the battlefield. OPH minimizes casualties through full spectrum surveillance, monitoring, and testing activities against environmental, biological, and chemical threats. Equipped and trained field sanitation and CBRN elements will establish tailored active and passive protection measures, resulting in more survivable formations. Army medical formations must integrate manned and unmanned air and surface systems to improve detection, diagnostics, and treatment. These formations must share information with all partners through a single, data-centric C2 system empowering both timely operational decisions and timely medical responses.
d. Healthcare Training and Education. Medical education and training must align with combat demands. This comprehensive approach will encompass all medical specialties, using advanced training methodologies like virtual reality, haptic feedback systems, and AI-driven simulations to develop and maintain skills. These technologies will provide realistic and repeatable opportunities for personnel to practice high-stress and complex scenarios, like trauma triage or prolonged care.
e. Advanced Diagnostics. In a combat environment, where split-second decisions can mean the difference between life and death, the benefits of advanced diagnostics are immeasurable. By incorporating cutting-edge technologies such as precision medicine, nanomedicine, robotics, telemedicine, and gene editing technology, Soldiers can experience optimized health and improved combat performance. Additionally, advanced diagnostics enable early detection of internal injuries, such as internal bleeding or organ damage, which may not be immediately evident. Swift identification of these hidden injuries allows medical personnel to intervene promptly and prevent further harm. Moreover, advanced diagnostics aid in identifying infectious diseases or exposure to hazardous agents (e.g., CBRN), thereby preventing outbreaks. Ultimately, the integration of advanced diagnostics in combat empowers medical teams to deliver timely and accurate care, leading to improved outcomes for wounded, injured, or ill Soldiers and enhanced operational efficiency.
f. Advanced Therapeutic Technology (ATT). ATT will play a critical role in supporting commanders and Army Medicine. In austere and contested environments, ATT will enhance Army Medicine's ability to rapidly triage and assess injuries, leveraging portable diagnostic devices and advanced imaging systems to determine the severity of injuries and provide timely treatment. The ability of ATT to track Soldiers' exposure to hazardous conditions, such as chemical agents or extreme temperatures, will also be crucial in protecting personnel from emerging threats.g. Advanced Treatment Modalities (ATMs). The integration of ATMs will revolutionize the way combat commanders operate in future operational environments. With the advent of cutting-edge technologies such as robotic surgery and portable diagnostic equipment, commanders will be empowered to make informed decisions that prioritize the health and safety of their troops. ATMs such as bioengineered skin substitutes and negative pressure wound therapy will be particularly critical in managing complex battlefield injuries, promoting faster wound healing, reducing infection risk, and enhancing long-term recovery. The combination of these advanced medical capabilities and technologies, including artificial intelligence, machine learning, and data analytics, will enable rapid and effective treatment of wounded personnel, reduce the risk of mortality and morbidity, and facilitate their swift return to duty.
-
Future supply lines will likely be disrupted, congested, and under constant threat. Predicted high casualty rates in future warfare requires Army medical forces to have predictable and reliable delivery of Class VIII at the point of need (PON). This will enable clearing the battlefield and maximizing RTD while facilitating expanded maneuver and survivable formations. In the FOE, the threat will likely target sustainment nodes from the homeland (industrial base) to the operational area, cutting off access to sustainment capabilities and resources. Compounding this problem is the demand to support widely distributed friendly forces.
a. Advanced Manufacturing. Advanced manufacturing can revolutionize logistics by enabling the production of essential supplies at or near the PON. This includes the production of Class VIII A/B medical supplies through synthetic biology and biomedical manufacturing.
b. Predictive medical logistics (MEDLOG). This capability uses advanced analysis to predict where and when medical supplies will be needed. It allows for the optimization of Class VIII supplies, which include medical materiel and equipment, across all echelons. By analyzing expected casualty rates and injury mechanisms, predictive MEDLOG enables planning and allocation of resources. Integration with partners and allies will additionally enhance this capability by using standardized equipment, supplies, and data-sharing protocols, ensuring that medical logistics systems work seamlessly across different military forces. At higher echelons, persistent assessment of the supply chain (from rare earth metals and active pharmaceutical ingredients to industrial-based capacity) must be conducted through the lens of risk to mission and risk to force.
c. Multimodal resupply. Multimodal resupply combines air, land, and maritime transportation with manned and unmanned systems to enhance resupply capabilities and reduce reliance on a single mode of transport. Air transport provides speed and agility for time-sensitive items, while land transport offers flexibility in various terrains. Maritime transport (both sea and river, surface and subsurface) handles larger quantities over longer distances. Manned systems provide adaptability, while unmanned and autonomous systems offer speed, precision, and reduced risk. This multimodal approach optimizes logistics operations, ensures timely supply delivery, and overcomes challenges in contested environments.
d. Distributed supply nodes. These nodes are strategically positioned throughout the operational area to ensure effective resupply. This approach offers several advantages, including reduced vulnerability to disruptions, resupply redundancy, and enhanced operational coordination. By having multiple supply nodes, military forces can mitigate disruptions in one area by relying on alternative nodes (to include those of partners and allies). Supplies can be sourced from the nearest available node, reducing transportation time and costs, and ensuring critical supplies reach the PON in a timely manner. Additionally, strategically positioned supply nodes enable better coordination and synchronization of logistics activities, optimizing resource distribution, and enhancing overall operational effectiveness while reducing strain on logistics capabilities. Robots and autonomous platforms specifically designed to operate in these supply nodes allow for additional flexibility.
e. Autonomous and semi-autonomous resupply systems. Autonomous and semi- autonomous resupply systems enhance logistics capabilities by reducing reliance on human intervention in contested logistics. These systems leverage advanced technologies to automate and streamline the resupply process, resulting in increased efficiency and flexibility while reducing risk. In addition, these systems can serve to enhance situational awareness by having their sensors gather data from their surroundings.
f. Tele-maintenance and remote diagnostics. These capabilities will enable medical logisticians to provide guidance and consultation from afar, minimizing the need for physical transportation of personnel and materiel. Advanced diagnostic tools and predictive maintenance algorithms can identify potential equipment failures before they occur, ensuring the highest levels of readiness.
-
There are functions that support two or more of the three medical imperatives outlined above.
a. Artificial Intelligence and Machine Learning. By using AI and ML to analyze vast amounts of data, patterns can be detected, outcomes can be more accurately predicted, and sound recommendations can be quickly developed for commanders. This allows medical personnel at all echelons and across all medical functions to act more quickly and decisively, ultimately reducing preventable deaths.
b. Human-machine teaming. This teaming involves leveraging the unique strengths of both humans and machines to achieve operational goals. Machines, equipped with AI and machine learning, can process, and analyze vast amounts of data at speeds far beyond human capabilities. This allows for real-time analytics of supply chain needs and predictive modeling for medical supply, evacuation, and treatment. The integration of human capabilities with advanced technological systems represents a transformative shift towards more efficient, responsive, and adaptive medical support on the battlefield.
c. Scalable, highly mobile multifunctional organizations. The FOE demands that medical units at all echelons be as mobile as the maneuver units they support to keep up with the rapid pace of military operations and to better ensure survivability. Medical organizations that are scalable and multifunctional will allow maneuver commanders increased flexibility in rapidly changing situations. In addition, medical units must decrease their signature (physical, electronic, etc.) to avoid enemy detection.
d. Interoperability with the Combined Joint Force. Interoperability with partners and allies is crucial for achieving success. It ensures that different medical forces can work together seamlessly, share information, and support each other's operations. This capability enhances mission success by leveraging the strengths and resources of multiple Services and nations, fostering mutual trust and cooperation. Moreover, interoperability helps in responding swiftly to global crises, maintaining regional stability, and deterring potential threats through a unified front. Ultimately, it strengthens collective defense and augments the Army's medical capabilities.
e. Health Engagement. Health engagement plays a significant role in winning in competition and being prepared for crisis and conflict. Through engagement with international health organizations, foreign militaries, and local healthcare systems, Army medical forces can foster collaboration, build trust, and promote a shared understanding of health security threats and responses. This, in turn, enhances interoperability with partners and allies, allowing for more effective coordination and cooperation in response to health crises and other operational challenges. Health engagement also allows for enhancing situational awareness.
f. Reach back. Reach back is an essential component for enhancing battlefield capability, capacity, and operational readiness. This approach will use advanced telepresence and telemedicine technologies, along with integrated data systems, to conserve a commander's fighting strength. Reach back improves real-time diagnostics and remote treatment, allowing medical personnel real-time remote access to specialized care. Furthermore, in an environment characterized by contested logistics, reach back can provide a lifeline, using virtual platforms to maintain continuity of care and resource allocation.
g. Operate in a CBRN environment. The best way to deter enemy CBRN use is to demonstrate that Army forces can effectively operate in a CBRN environment. The ability to rapidly assess threats, evacuate and treat patients, and resupply in contaminated areas is crucial to minimize preventable death and maximize RTD. Additionally, continued development of advanced deployable sensors that can observe current and emerging CBRN threats can help decrease those threats.
h. Medical Modeling and Simulations. Incorporating medical modeling and simulation in both training and in operational settings is crucial. By using advanced modeling techniques, medical professionals can simulate diverse medical scenarios, thereby optimizing treatment plans, forecast the spread of diseases, and evaluate casualties in complex operational environments. These simulations facilitate the development medical resource allocation plans, identifying potential bottlenecks in the treatment and evacuation process, and enhance preparedness in large-scale conflicts. Furthermore, modeling and simulation allows testing of various prevention and intervention strategies, aiding in the identification of the most efficient approaches to minimize casualties and improve overall outcomes.
Are there any additional benefits I would receive?
Beyond the direct award, MED CDID funding offers significant strategic advantages for companies operating in defense, medical technology, logistics, AI/ML, and dual-use innovation:
Government Validation and Credibility:
Being selected by the U.S. Army Medical Capability Development Integration Directorate demonstrates strong technical merit and alignment with Army 2040 operational needs. This validation can accelerate engagement with primes, program offices, integrators, and investors who prioritize government-vetted technologies.
Enhanced Visibility and Notoriety:
Although the BAA does not explicitly promise publicity, MED CDID-aligned innovations often surface in Army medical modernization discussions, technical exchanges, and defense-sector forums—raising your company’s profile across DoD medical, logistics, and capability development communities.
Ecosystem Access and Collaboration Opportunities:
Awardees gain direct interaction with MED CDID, Army Futures Command stakeholders, and operational medical units. These touchpoints can open pathways to experimentation events, requirements discussions, field evaluations, and future contracting opportunities with Army, Joint, and SOF medical acquisition organizations.
Stronger Exit and Acquisition Potential:
Nondilutive DoD funding that advances medical, logistics, or autonomy technologies—combined with Army validation—typically increases a company’s valuation and attractiveness to acquirers in defense, biotech, medtech, autonomy, and advanced manufacturing. Government-backed maturity substantially strengthens both commercial and dual-use exit potential.
What is the timeline to apply and when would I receive funding?
Open period: The announcement is open from its posting date through December 31, 2030, as an open-ended BAA.
Submission cadence: Vulcan Scout Cards may be submitted at any time during the open period, subject to the process in the BAA. The government may also issue separate, focused calls for follow-on white papers at any time while the BAA is active.
Multi-step process:
Vulcan Scout Card submission.
If of interest, MED CDID may request a white paper and/or
A formal technical and cost proposal.
The BAA does not specify review cycle timing or when funds would be awarded after a proposal is submitted. Actual award timing will depend on when MED CDID issues a request for proposal, internal evaluations, and contracting timelines.
Where does this funding come from?
This opportunity is issued by the U.S. Army Medical Capability Development Integration Directorate (MED CDID), which is responsible for enabling the Army Health System and developing future medical concepts and requirements for the Army and Joint Force
Who is eligible to apply?
The BAA does not restrict eligibility. Typical BAAs accept proposals from:
U.S. businesses of any size
Universities
Nonprofits
Federally-funded research and development centers (with limitations)
Foreign entities may be subject to additional restrictions depending on classification and export-control considerations.
What companies and projects are likely to win?
Based on the BAA’s emphasis, competitive projects are likely to:
Directly address one or more of the three MED CDID imperatives:
Clearing the battlefield (evacuation, prolonged care, integrated patient-movement C2).
Maximizing return to duty (resiliency, OPH, advanced diagnostics and treatment, training).
Overcoming contested logistics (advanced manufacturing, predictive MEDLOG, multimodal resupply).
Provide innovative, future-oriented solutions for the 2040 operational environment, not just incremental improvements to current practice.
Show clear relevance to the described FOE challenges (distributed forces, mass casualties, CBRN threats, urban operations, contested logistics).
Leverage cross-cutting enablers such as AI/ML, human-machine teaming, interoperability with joint and allied forces, and medical modeling and simulation to materially improve outcomes (reduced preventable deaths, higher RTD rates, more resilient logistics).
In short, teams that tightly map their concept to these problem statements and demonstrate operational impact for Corps-and-below medical units are best aligned with the BAA.
Are there any restrictions I should know about?
Tactical level focus: The BAA is focused on tactical-level (Army Corps and below) medical units, not broader health systems in isolation.
Targeted white papers: White papers should address only the specific portion of the BAA the offeror intends to accomplish. Submitting a single white paper that tries to cover the entire scope of the BAA is “most likely” to be rejected.
How long will it take me to prepare an application?
For a first-time applicant, preparing a competitive scout card under this BAA will likely take 20–30 hours in total.
How can BW&CO help?
Our team specializes in complex federal R&D proposals and can:
Triple your likelihood of success through proven strategy and insider-aligned proposal development
Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations
Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.
How much would BW&CO Charge?
Our full service support is available to submit a scout card for a flat fee of $2,500.
Fractional support is $300 per hour, with most scout card projects requiring 10-12 hours of work.
For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.